AR047064A1 - Lactobacilos probioticos para caninos y uso - Google Patents

Lactobacilos probioticos para caninos y uso

Info

Publication number
AR047064A1
AR047064A1 ARP040104777A ARP040104777A AR047064A1 AR 047064 A1 AR047064 A1 AR 047064A1 AR P040104777 A ARP040104777 A AR P040104777A AR P040104777 A ARP040104777 A AR P040104777A AR 047064 A1 AR047064 A1 AR 047064A1
Authority
AR
Argentina
Prior art keywords
strain
lactobacillus
composition
gastrointestinal tract
food
Prior art date
Application number
ARP040104777A
Other languages
English (en)
Inventor
Michael Anthony Ceddia
Thomas William-Maxwell Boileau
John Kevin Collins
Gary Mitchell Davenport
Barry Pius Kiely
Mahony Liam Diarmuid O
Gregory Dean Sunvold
Mark Alan Tetrick
Robert Jason Vickers
Original Assignee
Iams Company
Alimentary Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Company, Alimentary Health Ltd filed Critical Iams Company
Publication of AR047064A1 publication Critical patent/AR047064A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/177—Ruminis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/805—Pet food for dog, cat, bird, or fish
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Abstract

Una cepa de bacteria acidoláctica del género Lactobacilli obtenible mediante el aislamiento a partir del tracto gastrointestinal lavado y extirpado de caninos; la cepa tiene actividad probiotica. Dicha cepa tiene la habilidad de sobrevivir y colonizar el tracto gastrointestinal de un animal de companía, y tiene al menos 66% de crecimiento cuando se cultiva en presencia de 0,5% de sales biliares y es capaz de mantener su viabilidad después de 1 hora a un pH de 2,5. Dicha cepa es una especie seleccionada a partir del grupo que comprende las especies Lactobacillus murinus/ruminus, Lactobacillus crispatus, Lactobacillus acidophilus, Lactobacillus fermentum, Lactobacillus buchneri, Lactobacillus reuteri, Lactobacillus lactis o mezclas de los mismos. Una composicion que comprende una cepa de bacteria acidoláctica del género Lactobacilli obtenible mediante el aislamiento del tracto gastrointestinal lavado y extirpado de caninos que tenga actividad probiotica y un portador. Dicha composicion en donde la cepa se selecciona debido a su habilidad para sobrevivir y colonizar el tracto gastrointestinal de mascotas. Dicha composicion es un alimento para animales de companía, de preferencia alimento para perros o gatos. Dicha composicion es un alimento deshidratado para animales, alimento humedo para animales, galleta molida, galleta masticable, bizcocho, suplemento para animales de companía, caldo espeso, yogur, queso u otro producto lácteo, cápsula, tableta o pastilla.
ARP040104777A 2003-12-19 2004-12-20 Lactobacilos probioticos para caninos y uso AR047064A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53097203P 2003-12-19 2003-12-19

Publications (1)

Publication Number Publication Date
AR047064A1 true AR047064A1 (es) 2006-01-04

Family

ID=34710196

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104777A AR047064A1 (es) 2003-12-19 2004-12-20 Lactobacilos probioticos para caninos y uso

Country Status (10)

Country Link
US (3) US8894991B2 (es)
EP (4) EP2261321A1 (es)
JP (1) JP4503614B2 (es)
AR (1) AR047064A1 (es)
AT (1) ATE509093T1 (es)
AU (1) AU2004305121B2 (es)
BR (1) BRPI0417805A (es)
CA (1) CA2550294C (es)
ES (1) ES2366542T3 (es)
WO (1) WO2005060708A2 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US7785635B1 (en) * 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
AR052472A1 (es) * 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
WO2006130188A1 (en) * 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
GB0519164D0 (en) 2005-09-20 2005-10-26 Mars Inc Composition
WO2007060539A2 (en) * 2005-11-28 2007-05-31 Jorrocks Pty Ltd. Methods for preparation of animal feeds
US7682619B2 (en) * 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US20100172874A1 (en) * 2006-12-18 2010-07-08 The Washington University Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
US7910127B2 (en) * 2007-03-02 2011-03-22 Biogaia Ab Use of lactic acid bacteria for improving food lysine absorption of pet animals
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
JP5450630B2 (ja) * 2008-09-11 2014-03-26 ザ・アイムス・カンパニー タンパク質ベースコアを有する動物飼料キブル及び関連方法
EP2338976B1 (en) * 2008-09-30 2017-08-16 Meiji Co., Ltd. Lactic acid bacterium having high oxalic acid decomposition ability
JP5503142B2 (ja) * 2008-12-24 2014-05-28 勝徳 砂川 「泡盛蒸留圧搾粕」を利用した食材及びその脱臭処理装置
US20110104327A1 (en) * 2009-04-23 2011-05-05 Bacterfield International S.A. Probiotic pet food
AU2010254356A1 (en) 2009-05-28 2011-12-22 Mars, Incorporated Pet food in the form of a coated kibble
US8691303B2 (en) * 2009-07-31 2014-04-08 The Iams Company Dusted animal food
US9210945B2 (en) 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
US9173423B2 (en) 2009-07-31 2015-11-03 The Iams Company Animal food kibble with electrostatically adhered dusting
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US20110027417A1 (en) 2009-07-31 2011-02-03 Patrick Joseph Corrigan Process for Dusting Animal Food
FI122247B (fi) 2009-08-12 2011-10-31 Vetcare Oy Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi
RU2531316C2 (ru) 2010-01-22 2014-10-20 Дзе Иамс Компани Способ изготовления корма для домашних животных в форме гранул с покрытием
CA2697758A1 (en) * 2010-03-24 2011-09-24 Normerica Inc. Food composition comprising germinated seeds or grains
WO2012027519A2 (en) 2010-08-27 2012-03-01 The Iams Company Methods of measuring activities of daily living
CA2836256A1 (en) 2011-05-20 2012-12-06 Eric W. Brown Paenibacillus alvei strain ts-15 and its use in controlling pathogenic organisms
KR101166798B1 (ko) 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
US20130295227A1 (en) 2012-05-01 2013-11-07 Robbert H. ter Haar Composition Comprising a Sensitive Ingredient
BR112017017190B1 (pt) 2015-02-16 2022-08-30 Mars, Incorporated Método para produzir um alimento para animais de estimação
MX2017013715A (es) 2015-04-28 2018-03-02 Mars Inc Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado.
EP3696258A1 (en) * 2016-11-08 2020-08-19 Innolact Group Oy A lactic acid bacteria strain
US11766050B2 (en) * 2018-06-26 2023-09-26 Country Food, Llc Yogurt for dogs
CN114561318B (zh) * 2021-12-29 2022-11-08 云南农业大学 一株鼠乳杆菌及其在治疗ii型糖尿病中的应用
CN114836358B (zh) * 2022-06-28 2023-02-24 中国农业科学院北京畜牧兽医研究所 罗伊氏乳杆菌sxdt-32及其应用
CN116970539B (zh) * 2023-09-14 2023-12-15 中科微智（北京）生物科技有限公司 一种鼠联合乳杆菌、其组合物及用途

Family Cites Families (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540979A (en) 1948-04-24 1951-02-06 Smith Kline French Lab Enteric coating
BE634858A (es) 1962-07-19 1900-01-01
DE1204363B (de) 1963-09-10 1965-11-04 Hoffmann La Roche Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt
GB1190387A (en) 1966-05-24 1970-05-06 Green Cross Corp Enteric Coated Medicaments
US3677898A (en) 1969-01-31 1972-07-18 Ajinomoto Kk Acid protease and method of preparing the same
US3898132A (en) 1972-08-24 1975-08-05 Int Feed Improvement Ass Inc Method of preparing stowable, dormant bacteria
US3957974A (en) 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
JPS6038372B2 (ja) 1975-04-09 1985-08-31 日清製粉株式会社 犬の下痢予防および治療方法
JPS52102419A (en) 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
GB1595054A (en) 1977-11-14 1981-08-05 Metal Box Co Ltd Capsules containing micro-organisms
CH637297A5 (fr) 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
US4338346A (en) 1978-12-21 1982-07-06 The Procter & Gamble Company Non-nutritive sweetener
FR2453215A1 (fr) 1979-04-05 1980-10-31 Rhone Poulenc Ind Procede d'inclusion de micro-organismes dans une matrice de polymere
US4248857A (en) 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4411925A (en) 1980-01-21 1983-10-25 Pfizer Inc. Branched amides of L-aspartyl-d-amino acid dipeptides
US4332190A (en) * 1980-06-03 1982-06-01 First National Supermarkets, Inc. Spiral meat slicer
US4399163A (en) 1980-11-05 1983-08-16 Pfizer Inc. Branched amides of L-aspartyl-D-amino acid dipeptides
US4423029A (en) 1981-06-25 1983-12-27 The Procter & Gamble Company (S)-3-Amino-4-[(S,S)-1-(1-hydroxyethyl)alkyl amino]-4-oxo-butyric acid compounds suitable as non-nutritive sweetners
US4518696A (en) 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
US4592748A (en) 1984-05-18 1986-06-03 Vortex Research Corp. Yoghurt based douche kit and assembly therefor
CA1276394C (en) 1984-07-13 1990-11-13 John M. Janusz Alpha-l-aspartyl-d-phenylglycine esters and amides useful as high intensity sweeteners
SE463598B (sv) 1984-11-08 1990-12-17 Chemical Dynamics Sweden Ab Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
DE3678644D1 (de) 1985-08-16 1991-05-16 Procter & Gamble Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
DE3678643D1 (de) 1985-08-16 1991-05-16 Procter & Gamble Partikel mit konstanter wirkstofffreisetzung.
JPS62201823A (ja) 1986-02-28 1987-09-05 Freunt Ind Co Ltd 腸内有用細菌含有物およびその製造方法
US5160745A (en) 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
CA1300538C (en) 1986-08-01 1992-05-12 Robert Charley Maintenance of the viability of microorganisms for use in microbial inoculants
US4781939A (en) 1986-10-28 1988-11-01 Nestec, S.A. Layered meat emulsion product and method of producing same
US4816259A (en) 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
US4797289A (en) 1987-03-09 1989-01-10 Reddy Malireddy S Enhancement of lactobacillus acidophilus growth and viability in yogurt and other cultured dairy products
ATE332649T1 (de) 1987-05-01 2006-08-15 Biogaia Biolog Ab Reuterin enthaltende nährungszusammensetzung
US5413960A (en) 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
FI77573C (fi) 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
FR2615203B1 (fr) 1987-05-12 1989-08-18 Agronomique Inst Nat Rech Inoculum dans lequel les micro-organismes sont conditionnes sous la forme de granules biodegradables, son procede de preparation et ses applications
GB8713601D0 (en) 1987-06-10 1987-07-15 Unilever Plc Fermentation
US4859377A (en) 1987-07-10 1989-08-22 The United States Of America, As Represented By The Secretary Of Agriculture Starch encapsulation of entomopathogens
US4806368A (en) 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
DK686187D0 (da) 1987-12-23 1987-12-23 Hansens Chr Bio Syst Veterinaert praeparat
JPH01278781A (ja) 1988-05-02 1989-11-09 Nec Corp 不揮発性半導体記憶装置
DE68928665T2 (de) 1988-08-02 1998-11-12 Gastro Services Pty Ltd Behandlung von gastro-intestinalen krankheiten
IT1227154B (it) 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
IT1230576B (it) 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
AU5254790A (en) 1989-04-06 1990-10-11 Chugai Seiyaku Kabushiki Kaisha Process for preparing a therapeutic agent for rotavirus infection
US5540945A (en) 1989-05-11 1996-07-30 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
PT94108A (pt) 1989-05-24 1991-02-08 Asahi Chemical Ind Preparacao de microorganismos viaveis contendo esporos estabilizada,sua producao e pilulas respectivas
JPH06101994B2 (ja) 1989-08-16 1994-12-14 ユニコロイド株式会社 耐消化性腸内有用細菌及びその製法
PH27186A (en) 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
DE3933528C1 (es) 1989-10-04 1990-12-06 Effem Gmbh, 2810 Verden, De
SE465206B (sv) 1989-12-22 1991-08-12 Eva Grahn Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
US5198227A (en) 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
DK203090A (da) 1990-02-28 1991-08-29 Sitia Yomo Spa Maelkeagtig mousse, dens tilberedning og anvendelse
FI88856C (fi) 1990-05-18 1997-07-01 Alko Yhtioet Oy Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel
IE61651B1 (en) 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
FR2668081B1 (fr) 1990-10-19 1994-11-18 Lvmh Rech Procede et appareil de fabrication de particules solides a partir d'un materiau solidifiable en presence d'un agent de solidification en de bons rendements.
IT1244691B (it) 1991-01-29 1994-08-08 Sitia Yomo Spa Mousse lattea, suo impiego per preparare dessert e dessert cosi' ottenuti
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
FR2678166B1 (fr) 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
SE469875C (sv) * 1991-07-25 1997-02-05 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
WO1993002558A1 (en) 1991-08-01 1993-02-18 Biogaia Biologics Ab Method and formulation for reducing microbial populations
US5286495A (en) 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
AU680628B2 (en) 1992-08-20 1997-08-07 Schering Corporation Novel uses of IL-4 and/or IL-10, and antibodies against the same
US5403799A (en) 1992-12-21 1995-04-04 W. R. Grace & Co.-Conn. Process upset-resistant inorganic supports for bioremediation
JP3472317B2 (ja) 1993-02-26 2003-12-02 味の素ファルマ株式会社 被覆製剤
JPH08509965A (ja) 1993-03-15 1996-10-22 ファーマ・パシフィック・ピーティーワイ・リミテッド 治療剤および治療方法
IT1265092B1 (it) 1993-05-31 1996-10-30 Giuliani Spa Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon
GB9318439D0 (en) 1993-09-06 1993-10-20 Zeneca Ltd Probiotics
US5733568A (en) 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
JP3559790B2 (ja) 1993-12-20 2004-09-02 松谷化学工業株式会社 食品にビフィズス菌の増殖促進作用を付与する方法
US5486507A (en) 1994-01-14 1996-01-23 Fuisz Technologies Ltd. Porous particle aggregate and method therefor
IT1270216B (it) 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
US5849327A (en) 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US5531988A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5733540A (en) 1995-03-08 1998-03-31 Lee; Peter Poon-Hang Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
JPH08242763A (ja) 1995-03-10 1996-09-24 Morishita Jintan Kk カプセル化された腸内有用細菌を含有するヨーグルト
CR5278A (es) 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
IT1276783B1 (it) 1995-06-23 1997-11-03 Bracco Spa Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
US5785990A (en) 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
FI102298B (fi) 1995-09-07 1998-11-13 Oulutech Oy Menetelmä maitohappobakteerilajien määrittämiseksi ja menetelmään sove ltuvia oligonukleotideja
US5702679A (en) 1995-10-06 1997-12-30 Kerr-Mcgee Chemical Corp. Method of preparing Li1+X- Mn2-X O4 for use as secondary battery
US6506389B2 (en) 1995-10-20 2003-01-14 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno) Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
US5853697A (en) 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
AT405235B (de) 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
AUPN698495A0 (en) 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
GB2311027B (en) 1996-03-15 1999-10-27 Johnson & Johnson Medical Coated bioabsorbable beads for wound treatment
RU2086248C1 (ru) 1996-04-02 1997-08-10 Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов Пробиотический препарат "стрептобифид" для животных
US5766520A (en) 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US5660790A (en) 1996-08-13 1997-08-26 Litmus Concepts, Inc. PH and amine test elements
WO1998023727A1 (en) 1996-11-29 1998-06-04 Bio K + International Inc. Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
AU5310898A (en) 1996-12-20 1998-07-17 Dumex-Alpharma A/S Release-controlled coated tablets
US5952033A (en) 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
ES2164299T5 (es) 1997-01-09 2009-03-01 Societe Des Produits Nestle S.A. Producto cereal que contiene probioticos.
NZ337505A (en) 1997-02-11 2001-07-27 Univ College Cork Nat Univ Ie Isolated antimicrobial agents from Lactobacillus salivarius
AU2809899A (en) 1997-03-18 1999-07-22 Mendel Institute For Nutraceutical Research Inc, The Dosing beverage with a bacteria formulation
US6133323A (en) 1997-04-09 2000-10-17 The Iams Company Process for enhancing immune response in animals using β-carotene as a dietary supplement
CA2287451C (en) 1997-04-18 2014-06-10 Sean Farmer Topical use of probiotic bacillus spores to prevent or control microbial infections
CA2292536A1 (en) 1997-06-03 1998-12-10 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with sids
IT1292636B1 (it) 1997-06-20 1999-02-08 Ascor Chimici Srl Composizione a rilascio controllato di sostanze biologicamente attive ad uso zootecnico.
RU2123343C1 (ru) 1997-06-26 1998-12-20 Алин Борис Иннокентьевич Способ получения капсул, содержащих бактерии b.bifidum (бифидумбактерин сухой в капсулах)
US5976579A (en) 1997-07-03 1999-11-02 Mclean; Linsey Nutritional supplement for the prevention and treatment of excessive intestinal permeability
FI108512B (fi) 1997-08-22 2002-02-15 Danisco Finland Oy Tahnamainen nautittavaksi tarkoitettu koostumus, sen käyttö ja sitä sisältävät tuotteet
NZ503086A (en) 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
KR100387245B1 (ko) 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
AR014129A1 (es) 1997-12-17 2001-02-07 Nutrasweet Co Bebida que comprende fundamentalmente un ester n-[n-(3,3-dimetilbutil)-l- alfa-aspartil]-l-fenilamina 1 - metilico, bebida sin alcohol carbonatada,bebida de jugo, bebida envasada caliente y bebida deportiva de bajas calorias.
WO1999048372A1 (en) 1998-03-23 1999-09-30 General Mills, Inc. Encapsulation of components into edible products
FI104405B (fi) 1998-03-27 2000-01-31 Valtion Teknillinen Mikro-organismeja sisältävät tärkkelyskapselit ja niiden valmistusmenetelmä
US5932258A (en) 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
DE19819475A1 (de) 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
PT956858E (pt) 1998-04-30 2002-04-29 Renata Maria Anna Caval Vesely Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
AU4549699A (en) 1998-07-30 2000-02-21 Warner-Lambert Company Centerfill delivery system for nutraceuticals
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
IT1304170B1 (it) 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
JP2000191519A (ja) 1998-12-25 2000-07-11 Nippon Kayaku Co Ltd 薬効成分の不快な官能的性質が隠蔽された速放性粒状物
DE19860375A1 (de) 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US6692779B2 (en) 1999-03-26 2004-02-17 The Pillsbury Company Food products with biocontrol preservation
IL146438A0 (en) 1999-05-27 2002-07-25 Iams Company Process and product for enhancing immune response in companion animal using a combination of antioxidants
DE19937361A1 (de) 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
AU2001278432B2 (en) * 2000-05-25 2007-08-30 Societe Des Produits Nestle S.A. Novel probiotics for pet food applications
US6571229B1 (en) 2000-05-31 2003-05-27 Motorola, Inc. Method and apparatus for inerative training of a classification system
KR100459564B1 (ko) * 2000-06-21 2004-12-03 삼성전자주식회사 이동통신시스템에서 서비스 부하를 단말기에 보고하기위한 장치 및 방법
ATE419331T1 (de) 2000-08-25 2009-01-15 Wakamoto Pharma Co Ltd L. salivarius-stamm enthaltende probiotische produkte
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
JP5186077B2 (ja) * 2000-12-18 2013-04-17 プロバイオヘルス・エルエルシー ラクトバシラス−カゼイｋｅ０１株から得られたプロバイオティック化合物
US20030190314A1 (en) * 2001-01-30 2003-10-09 The Lauridsen Group Methods and compositions of treatment for modulating the immune system of animals
NZ527930A (en) 2001-03-16 2005-11-25 Andrx Pharmaceuticals Llc Controlled release sulfonylurea formulation
AU2002249531A1 (en) 2001-04-02 2002-10-28 Alimentary Health Limited Immunotherapy based on dendritic cells
PE20030284A1 (es) 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de bifidobacterium
PE20030274A1 (es) 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
PE20030283A1 (es) 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
MXPA04004747A (es) 2001-11-23 2004-08-02 Procter & Gamble Forma de dosificacion farmaceutica con multiples recubrimientos.
US20030143293A1 (en) * 2002-01-31 2003-07-31 Sergei Shushunov Compositions and methods for treating diarrhea
GB0212975D0 (en) * 2002-06-06 2002-07-17 Mars Uk Ltd Mammalian animal composition
US7122370B2 (en) 2003-01-14 2006-10-17 Randolph Stanley Porubcan Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum

Also Published As

Publication number Publication date
US20050158293A1 (en) 2005-07-21
EP1718154A4 (en) 2007-10-03
EP2261321A1 (en) 2010-12-15
EP1718154A2 (en) 2006-11-08
JP2007513639A (ja) 2007-05-31
EP2261319A1 (en) 2010-12-15
WO2005060708A2 (en) 2005-07-07
CA2550294C (en) 2014-04-22
US20080292604A1 (en) 2008-11-27
BRPI0417805A (pt) 2007-04-10
ATE509093T1 (de) 2011-05-15
US7906112B2 (en) 2011-03-15
AU2004305121B2 (en) 2009-01-22
ES2366542T3 (es) 2011-10-21
WO2005060708A3 (en) 2005-09-22
EP1718154B1 (en) 2011-05-11
JP4503614B2 (ja) 2010-07-14
US20160002590A1 (en) 2016-01-07
AU2004305121A1 (en) 2005-07-07
US8894991B2 (en) 2014-11-25
EP2261320A1 (en) 2010-12-15
CA2550294A1 (en) 2005-07-07

Similar Documents

Publication Publication Date Title
AR047064A1 (es) Lactobacilos probioticos para caninos y uso
AR047065A1 (es) Bifidobacterium pseudolongum probioticas de caninos y uso
AR047294A1 (es) Bifidobacterium globosum probiotica de caninos y uso
Kongnum et al. Effect of Lactobacillus plantarum isolated from digestive tract of wild shrimp on growth and survival of white shrimp (Litopenaeus vannamei) challenged with Vibrio harveyi
AR052472A1 (es) Lactobacilos probioticos para felinos
Murry et al. Inhibition of growth of Escherichia coli, Salmonella typhimurium, and Clostridia perfringens on chicken feed media by Lactobacillus salivarius and Lactobacillus plantarum
Vázquez et al. Effects of lactic acid bacteria cultures on pathogenic microbiota from fish
JP3028214B2 (ja) 鳥類用生菌剤の投与方法
ES2607988T3 (es) Bifidobacterias probióticas felinas
CN101171019B (zh) 免疫功能调节剂
JPWO2019230183A1 (ja) 乳酸菌及びその用途
Gupta et al. Growth performance, feed utilization, digestive enzyme activity, innate immunity and protection against Vibrio harveyi of freshwater prawn, Macrobrachium rosenbergii fed diets supplemented with Bacillus coagulans
CN101563447A (zh) 用于预防和/或治疗变形链球菌群引起的龋的用途和方法
IL152695A (en) Probiotic for pet food apps
CN108243988A (zh) 一种有健齿功能的宠物咬胶及其制备方法
CA2380849C (en) New bifidobacteria preventing diarrhea caused by pathogenic bacteria
Zoumpopoulou et al. Probiotics and prebiotics: an overview on recent trends
Kiers et al. Inhibition of adhesion of enterotoxigenic Escherichia coli K88 by soya bean tempe
CN1793330A (zh) 一种新型高活性乳酸菌制品的制备方法
JP2008013534A (ja) ペット用プロバイオティクス製品
JP6931718B2 (ja) 抗ウイルス効果及び免疫調節効能を有するラクトバチルス・プランタルムｃｊｌｐ４７５菌株及びそれを含む組成物
JP3765983B2 (ja) 病原菌およびロタウイルスが原因となる下痢を予防できるラクトバチルス菌株
JP2021516069A (ja) 抗ウイルス及び免疫調節効能を有するラクトバチルス・プランタルムｃｊｌｐ１７及びそれを含む組成物
RU2555549C2 (ru) ШТАММ Bacillus sp. ДЛЯ БИОЛОГИЧЕСКОЙ БОРЬБЫ С Saprolegnia sp. И ЕГО ПРИМЕНЕНИЯ
Palaniyandi et al. In vitro characterization of Lactobacillus plantarum strains with inhibitory activity on enteropathogens for use as potential animal probiotics

Legal Events

Date Code Title Description
FG Grant, registration